23andMe Holding and the Colorectal Cancer Alliance announced a collaboration to help advance research on colorectal cancer in the Black/African American community. The Genetic Insights into Colorectal Cancer in the Black Community Study is part of 23andMe’s continued efforts to raise awareness about important health conditions that touch many individuals but disproportionately impact the Black community. Through this study, 23andMe and the Alliance aim to recruit individuals who have African ancestry or identify as Black, African American, or of African descent who have been diagnosed with colorectal cancer, which includes colon cancer and cancer of the rectum.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ME:
- 23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
- 23andMe Reveals Promising Data for New Antibody at ASCO
- 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
- Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
- 23andMe conducted largest study of LRRK2 G2019S